Does early disease progression predict survival after first line‐treatment of Waldenström macroglobulinemia?

In symptomatic Waldenström macroglobulinemia (sWM) patients, prognosis is assessed with the international prognostic scoring system (IPSSWM). In follicular lymphoma and other B‐cell and T‐cell lymphomas, disease progression within 24 months (POD24) or (in patients without POD24) after 24 months has...

Descripción completa

Detalles Bibliográficos
Autores principales: Labreuche, Julien, Assouan, Deborah, Durot, Eric, Tomowiak, Cecile, Roos‐Weil, Damien, Toussaint, Elise, Bijou, Fontanet, Lemal, Richard, Brion, Annie, Laribi, Kamel, Ysebaert, Loic, Duhamel, Alain, Morel, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541850/
https://www.ncbi.nlm.nih.gov/pubmed/35385885
http://dx.doi.org/10.1002/hon.2996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541850/
https://www.ncbi.nlm.nih.gov/pubmed/35385885
http://dx.doi.org/10.1002/hon.2996

Ejemplares similares